Metrics to compare | 237690 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship237690PeersSector | |
|---|---|---|---|---|
P/E Ratio | 19.8x | 7.5x | −0.3x | |
PEG Ratio | 0.17 | 0.04 | 0.00 | |
Price/Book | 2.4x | 0.8x | 2.6x | |
Price / LTM Sales | 3.9x | 0.6x | 2.8x | |
Upside (Analyst Target) | 103.3% | 52.2% | 67.2% | |
Fair Value Upside | Unlock | 20.2% | 10.1% | Unlock |
ST Pharm Co.,Ltd., provides manufacturing services for active pharmaceutical ingredient and intermediate. The company offers small molecule and generics, an ingredient for treating viral infections; oligonucleotide based products, such as siRNA/microRNA, antisense, aptamer, decoys, and other novel oligos; monomer; and mRNA for vaccines and therapeutics. It also offers pre-clinical and bioanalytical research and development solutions. The company was formerly known as Samchully Pharmaceutical Company., Ltd. ST Pharm Co. Ltd. was founded in 1983 and is headquartered in Siheung-si, South Korea.